Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

about

Expression and activity of multidrug resistance proteins in mature endothelial cells and their precursors: A challenging correlation.

P2860

Q36284267-7CC36C50-BF96-47B3-817E-6413C8C246F9

P2860

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

Item

http://www.wikidata.org/entity/Q39341118

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

@en

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

@nl

type

Item

label

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

@en

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

@nl

prefLabel

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

@en

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

@nl

P1476

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

@en

P2093

András Apjok

http://www.w3.org/2001/XMLSchema#string

János Kappelmayer

http://www.w3.org/2001/XMLSchema#string

Katalin Tauberné Jakab

http://www.w3.org/2001/XMLSchema#string

Zsuzsa Hevessy

http://www.w3.org/2001/XMLSchema#string

P2860

A multidrug resistance transporter from human MCF-7 breast cancer cells

The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein

Calcein assay for multidrug resistance reliably predicts therapy response and survival rate in acute myeloid leukaemia

Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML)

The multidrug resistance protein family.

Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.

Fludarabine-based induction therapy does not overcome the negative effect of ABCG2 (BCRP) over-expression in adult acute myeloid leukemia patients.

MDR1/P-GP expression as a prognostic factor in acute leukemias.

Structural, mechanistic and clinical aspects of MRP1.

Vanadate trapping of nucleotide at the ATP-binding sites of human multidrug resistance P-glycoprotein exposes different residues to the drug-binding site

P304

117-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27683427

http://www.w3.org/2001/XMLSchema#string

P932

4975307

http://www.w3.org/2001/XMLSchema#string

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

about

P2860

P2860

Prediction of Therapy Response and Prognosis in Leukemias by Flow Cytometric MDR Assays.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932

P1433

P1476

P2093

P2860

P304

P31

P433

P478

P577

P698

P932